Septic Shock
📧 Sign up to get email alerts when something new happens for Septic Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-29Clinical Trial Update: Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock [NA]
ClinicalTrials.gov indicates the pilot Bevacizumab study in septic shock has been withdrawn; sponsor is Beth Israel Deaconess Medical Center…
-
CLINICAL_TRIALS withdrawal · 2024-08-16Clinical Trial Update: Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock in Angers University Hospital
A clinical trial evaluating norepinephrine and volume expansion on capillary refill time in septic shock at Angers University Hospital was w…
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure. [Phase 2]
A Phase 2 trial evaluating human albumin treatment in adults with septic shock has been withdrawn. The sponsor is Albimmune SL.
-
CLINICAL_TRIALS withdrawal · 2024-03-15Clinical Trial Update: Angiotensin II vs. Vasopressin in Septic Shock [Phase 4]
Phase 4 clinical trial comparing Angiotensin II versus Vasopressin in septic shock has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-01-18Clinical Trial Update: Vitamin C to Reduce Vasopressor Dose in Septic Shock [Phase 3]
Phase 3 trial investigating vitamin C to reduce vasopressor dose in septic shock has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-01-11Clinical Trial Update: Midodrine in the Recovery Phase of Septic Shock [Phase 3]
A Phase 3 clinical trial of midodrine in the recovery phase of septic shock was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock [Phase 3]
Phase 3 trial evaluating a continuous infusion of esmolol to affect stroke volume in hyperdynamic vasoplegic septic shock has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock [Phase 4]
A Phase 4 trial comparing norepinephrine alone versus norepinephrine plus vasopressin for septic shock was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-06Clinical Trial Update: Midodrine During Recovery From Septic Shock [Phase 4]
Phase 4 trial evaluating midodrine for recovery from septic shock has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study
Conscious Study, a trial investigating cerebral oxygenation in septic shock patients receiving vasopressors, has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-02-24Clinical Trial Update: Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis [Phase 2]
A Phase 2 trial evaluating early metabolic support for treating multi-organ dysfunction in severe sepsis has been withdrawn from the registr…
-
CLINICAL_TRIALS withdrawal · 2017-01-13Clinical Trial Update: Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis
A clinical trial investigating neutrophil FFA2/GPR43 receptor expression in sepsis patients has been withdrawn. The study included condition…
-
CLINICAL_TRIALS withdrawal · 2016-03-04Clinical Trial Update: Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients [Phase 2]
Phase 2 clinical trial evaluating selenium replacement in patients with severe sepsis and septic shock has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-24Clinical Trial Update: Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock [Phase 3]
A Phase 3 trial investigating the effect of fludrocortisone on norepinephrine-mean arterial pressure dose-response in septic shock has been …